Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.11), $0.27 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.